⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5632709 | 0.72 | — | — | |
| SCHEMBL131528 | 0.72 | — | — | |
| Acetonitrile SCHEMBL28196499 | 0.68 | — | — | |
| Hydrochloric Acid SCHEMBL11772599 | 0.68 | — | — | |
| Fluoride SCHEMBL27878304 | 0.68 | — | — | |
| Ammonia Solution, Strong SCHEMBL29264260 | 0.68 | — | — | |
| SCHEMBL28176807 | 0.68 | — | — | |
| Methylamine SCHEMBL4455335 | 0.62 | — | — | |
| SCHEMBL4835 | 0.61 | — | — | |
| Propyne SCHEMBL6450471 | 0.58 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3030583-B1 | CELLULOSE SUBSTRATE WITH ANTI-FLAME PROPERTIES AND RELATIVE PRODUCTION METHOD | TORCITURA PADANA S P A (IT) | 2017-05-03 | — | — | EP | claimed |
| US-7913541-B2 | Acoustic wave sensing devices; enhanced sensing due to the amino groups reacting with CO2 | HONEYWELL INTERNATIONAL INC. (US) | 2011-03-29 | — | — | US | claimed |
| EP-1763526-B1 | 4,6-DISUBSTITUTED PYRIMIDINES AND THEIR USE AS PROTEIN KINASE INHIBITORS | BAYER SCHERING PHARMA AG (DE) | 2009-06-24 | — | — | EP | claimed |
| EP-1988390-A2 | Matrix nanocomposite containing aminocarbon nanotubes for carbon dioxide detection | Honeywell International Inc. (US) | 2008-11-05 | — | — | EP | claimed |
| US-20080264147-A1 | Matrix nanocomposite containing aminocarbon nanotubes for carbon dioxide sensor detection | HONEYWELL INTERNATIONAL INC. | 2008-10-30 | — | — | US | claimed |
| US-20070208034-A1 | 4,6-disubstituted pyrimidines and their use as protein kinase inhibitors | ATLANTA PHARMA AG (DE) | 2007-09-06 | — | — | US | claimed |
| EP-1763526-A1 | 4,6-DISUBSTITUTED PYRIMIDINES AND THEIR USE AS PROTEIN KINASE INHIBITORS | Altana Pharma AG (DE) | 2007-03-21 | — | — | EP | claimed |
| WO-2006000589-A1 | 4,6-DISUBSTITUTED PYRIMIDINES AND THEIR USE AS PROTEIN KINASE INHIBITORS | ALTANA PHARMA AG (DE) | 2006-01-05 | — | — | WO | claimed |
| EP-0074304-B1 | TRICYCLIC ETHERS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN PHARMACEUTICAL PREPARATIONS | ADIR (FR) | 1985-04-03 | — | — | EP | claimed |
| EP-2287156-B1 | 2,4-Di(phenylamino)-pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders | NOVARTIS AG (CH) | 2013-05-29 | — | — | EP | disclosed |
| EP-2275413-B1 | 2,4-di(phenylamino)-pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders | NOVARTIS AG (CH) | 2013-03-06 | — | — | EP | disclosed |
| US-8263590-B2 | Pyrimidine derivatives | NOVARTIS AG (CH) | 2012-09-11 | — | — | US | disclosed |
| EP-1660458-B1 | 2, 4-PYRIMIDINEDIAMINES USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES, INFLAMMATORY AND IMMUNE SYSTEM DISORDERS | NOVARTIS AG (CH) | 2012-01-25 | — | — | EP | disclosed |
| US-20110201606-A1 | PYRIMIDINE DERIVATIVES | NOVARTIS AG (CH) | 2011-08-18 | — | — | US | disclosed |
| WO-2006000589-A1 | 4,6-DISUBSTITUTED PYRIMIDINES AND THEIR USE AS PROTEIN KINASE INHIBITORS | ALTANA PHARMA AG (DE) | 2006-01-05 | — | — | WO | disclosed |
| EP-1606265-A1 | 2, 4- DI (PHENYLAMINO) PYRIMIDINES USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES, INFLAMMATORY AND IMMUNE SYSTEM DISORDERS | Novartis AG (CH) | 2005-12-21 | — | — | EP | disclosed |
| WO-2005016894-A1 | 2, 4-PYRIMIDINEDIAMINES USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES, INFLAMMATORY AND IMMUNE SYSTEM DISORDERS | NOVARTIS AG (CH) | 2005-02-24 | — | — | WO | disclosed |
| WO-2004080980-A1 | 2, 4- DI (PHENYLAMINO) PYRIMIDINES USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES, INFLAMMATORY AND IMMUNE SYSTEM DISORDERS | NOVARTIS AG (CH) | 2004-09-23 | — | — | WO | disclosed |
| EP-0837682-A1 | THERAPEUTIC USE OF 1-AMINO-3-(N,N-DIMETHYLAMINO)-PROPYLIDEN-1,1-BISPHOSPHONIC ACID AND ITS SALTS | GADOR S.A. (AR) | 1998-04-29 | — | — | EP | disclosed |
| WO-1997002827-A1 | THERAPEUTIC USE OF 1-AMINO-3-(N,N-DIMETHYLAMINO)-PROPYLIDEN-1,1-BISPHOSPHONIC ACID AND ITS SALTS | GADOR S.A. (AR) | 1997-01-30 | — | — | WO | disclosed |